Publication

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

Scientific Reports 10(1):1148, 2020

Ægidius HM, Veidal SS, Feigh M, Hallenborg P, Puglia M, Vrang N, Jelsing J, Kornum BR, Blagoev B, Rigbolt KTG

Share this page

Resource Library

Related resources

A3907, a novel inhibitor of bile acid transport in the intestine and the kidney, improves markers of metabolic and hepatic pathology and reduces NAFLD activity score and fibrosis stage in a diet-induced and biopsy-confirmed mouse model of nonalcoholic steatohepatitis

Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals

Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease

Hepatoprotective effects of the long-acting FGF21 analogue PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650